These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 34049911

  • 1. Efficacy of calcium dobesilate in treating Chinese patients with mild-to-moderate non-proliferative diabetic retinopathy (CALM-DR): protocol for a single-blind, multicentre, 24-armed cluster-randomised, controlled trial.
    Hu H, Liu J, Wang D, Qiu S, Yuan Y, Wang F, Wen L, Song Q, Sun ZL.
    BMJ Open; 2021 May 28; 11(5):e045256. PubMed ID: 34049911
    [Abstract] [Full Text] [Related]

  • 2. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
    Ribeiro ML, Seres AI, Carneiro AM, Stur M, Zourdani A, Caillon P, Cunha-Vaz JG, DX-Retinopathy Study Group.
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec 28; 244(12):1591-600. PubMed ID: 16763797
    [Abstract] [Full Text] [Related]

  • 3. Effect of Chinese Patent Medicines on Ocular Fundus Signs and Vision in Calcium Dobesilate-Treated Persons With Non-Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
    Zhang Y, An X, Duan L, Jin D, Duan Y, Zhou R, Zhang Y, Kang X, Lian F.
    Front Endocrinol (Lausanne); 2022 Dec 28; 13():799337. PubMed ID: 35370950
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Microinvasive pars plana vitrectomy versus panretinal photocoagulation in the treatment of severe non-proliferative diabetic retinopathy (the VIP study): study protocol for a randomised controlled trial.
    Zheng W, Chen S, Ding X, Lai K, Xiao S, Lin Y, Liu B, Jin L, Li J, Wu Y, Ma Y, Lu L, Liu Y, Li T.
    BMJ Open; 2021 Feb 22; 11(2):e043371. PubMed ID: 33619191
    [Abstract] [Full Text] [Related]

  • 6. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P, Mistry H, Auguste P, Shyangdan D, Freeman K, Lois N, Waugh N.
    Health Technol Assess; 2015 Jul 22; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial.
    Scott IU, Jackson GR, Quillen DA, Larsen M, Klein R, Liao J, Holfort S, Munch IC, Gardner TW.
    JAMA Ophthalmol; 2014 May 22; 132(5):535-43. PubMed ID: 24604308
    [Abstract] [Full Text] [Related]

  • 9. Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis.
    Zhang X, Liu W, Wu S, Jin J, Li W, Wang N.
    Sci China Life Sci; 2015 Jan 22; 58(1):101-7. PubMed ID: 25528255
    [Abstract] [Full Text] [Related]

  • 10. Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.
    Adank C, Koerner F.
    Ophthalmologica; 1985 Jan 22; 190(2):102-11. PubMed ID: 3982791
    [Abstract] [Full Text] [Related]

  • 11. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
    Stamper RL, Smith ME, Aronson SB, Cavender JC, Cleasby GW, Fung WE, Becker B.
    Ophthalmology; 1978 Jun 22; 85(6):594-606. PubMed ID: 353623
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial.
    Scott IU, Jackson GR, Quillen DA, Klein R, Liao J, Gardner TW.
    JAMA Ophthalmol; 2014 Sep 22; 132(9):1137-42. PubMed ID: 24969516
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The comparative effects of oral Chinese patent medicines in non-proliferative diabetic retinopathy: A Bayesian network meta-analysis of randomized controlled trials.
    Liu Z, Chen Y, Jie C, Wang J, Deng Y, Hou X, Li Y, Cai W.
    Front Endocrinol (Lausanne); 2023 Sep 22; 14():1144290. PubMed ID: 37077355
    [Abstract] [Full Text] [Related]

  • 17. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
    Leite EB, Mota MC, de Abreu JR, Cunha-Vaz JG.
    Int Ophthalmol; 1990 Mar 22; 14(2):81-8. PubMed ID: 2187006
    [Abstract] [Full Text] [Related]

  • 18. Effect of Chinese herbal compounds on ocular fundus signs and vision in conventional treated-persons with non-proliferative diabetic retinopathy: A systematic review and meta-analysis.
    Li X, Zhang J, He R, Su X, Li Z, Xie X.
    Front Endocrinol (Lausanne); 2022 Mar 22; 13():977971. PubMed ID: 36034416
    [Abstract] [Full Text] [Related]

  • 19. Artificial intelligence-supported diabetic retinopathy screening in Tanzania: rationale and design of a randomised controlled trial.
    Cleland CR, Bascaran C, Makupa W, Shilio B, Sandi FA, Philippin H, Marques AP, Egan C, Tufail A, Keane PA, Denniston AK, Macleod D, Burton MJ.
    BMJ Open; 2024 Jan 25; 14(1):e075055. PubMed ID: 38272554
    [Abstract] [Full Text] [Related]

  • 20. Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.
    Solà-Adell C, Bogdanov P, Hernández C, Sampedro J, Valeri M, Garcia-Ramirez M, Pasquali C, Simó R.
    Curr Eye Res; 2017 Sep 25; 42(9):1273-1286. PubMed ID: 28574750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.